Progressive Familial Intrahepatic Cholestasis Type 3: a Novel Mutation in a Saudi Child

Progressive familial intrahepatic cholestasis type 3 (PFIC3) is caused by defects in ABCB4 gene. Liver histology although important, but is nonspecific, and molecular genetic testing is essential for diagnosis. To report PFIC3 in a Saudi male child and determine the pathogenetic role of a novel of ABCB4 in one of them. Liver biopsy, immunohistochemical analysis for MDR3 protein expression and molecular genetic analysis were done for the patient. Liver biopsy showed extensive ductular reaction with portal and periportal fibrosis. Immunohistochemical analysis revealed absence of MDR3 protein expression at the canalicular pole. Molecular genetic analysis revealed a novel mutation in ABCB4: the c.1783 C > T (p.Arg595X) mutation in exon 15 in homozygous state. A novel loss-of-function mutation has been identified. Molecular genetic testing is essential and conclusive for diagnosis.

[1]  F. Callea,et al.  Two novel mutations in African and Asian children with progressive familial intrahepatic cholestasis type 3. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[2]  E. Jacquemin,et al.  The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects. , 2010, Seminars in liver disease.

[3]  C. Paulusma,et al.  Progressive familial intrahepatic cholestasis type 1. , 2010, Seminars in liver disease.

[4]  J. Boyer,et al.  The Bile Salt Export Pump: Clinical and Experimental Aspects of Genetic and Acquired Cholestatic Liver Disease , 2010, Seminars in liver disease.

[5]  E. Jacquemin,et al.  Liver diseases related to MDR3 (ABCB4) gene deficiency. , 2009, Frontiers in bioscience.

[6]  M. Seia,et al.  Molecular characterization and structural implications of 25 new ABCB4 mutations in progressive familial intrahepatic cholestasis type 3 (PFIC3) , 2007, European Journal of Human Genetics.

[7]  O. Rosmorduc,et al.  Low phospholipid associated cholelithiasis: association with mutation in the MDR3/ABCB4 gene , 2007, Orphanet journal of rare diseases.

[8]  M. Trauner,et al.  MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes. , 2007, Seminars in liver disease.

[9]  B. Shneider.  Progressive intrahepatic cholestasis: Mechanisms, diagnosis and therapy , 2004, Pediatric transplantation.

[10]  Y. Jeng,et al.  FIC1 and BSEP defects in Taiwanese patients with chronic intrahepatic cholestasis with low gamma-glutamyltranspeptidase levels. , 2002, The Journal of pediatrics.

[11]  L. Frulloni,et al.  Progressive familial intrahepatic cholestasis. , 2002, Acta bio-medica : Atenei Parmensis.

[12]  R. Houwen,et al.  FIC1 disease: a spectrum of intrahepatic cholestatic disorders. , 2001, Seminars in liver disease.

[13]  Y. Jeng,et al.  Progressive Familial Intrahepatic Cholestasis with High γ-Glutamyltranspeptidase Levels in Taiwanese Infants: Role of MDR3 Gene Defect? , 2001, Pediatric Research.

[14]  P. Bosma,et al.  The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. , 2001, Gastroenterology.

[15]  E. Jacquemin,et al.  Progressive familial intrahepatic cholestasis. Genetic basis and treatment. , 2000, Clinics in liver disease.